Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA topoisomerases as molecular targets for anticancer drugs
Kamila Buzun, Anna Bielawska, Krzysztof Bielawski, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 1781-1799
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation
Yichao Wan, Guoqing Fang, Hongjuan Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113837-113837
Closed Access | Times Cited: 136
Lactones: Classification, synthesis, biological activities, and industrial applications
Suélen Karine Sartori, Marisa Alves Nogueira Diaz, Gaspar Diaz‐Muñoz
Tetrahedron (2021) Vol. 84, pp. 132001-132001
Closed Access | Times Cited: 103
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 46
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 39
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 13
New series of fluoroquinolone derivatives as potential anticancer Agents: Design, Synthesis, in vitro biological Evaluation, and Topoisomerase II Inhibition
Mina E. Adly, Azza T. Taher, Fakher M. Ahmed, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108163-108163
Closed Access | Times Cited: 1
Unboxing the molecular modalities of mutagens in cancer
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 72
Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Muhammad Sohail, Zheng Sun, Yanli Li, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 12, pp. 1385-1398
Closed Access | Times Cited: 64
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 63
Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
Prasanna Anjaneyulu Yakkala, Naveen Reddy Penumallu, Syed Shafi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1456-1456
Open Access | Times Cited: 28
A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
Cosmas O. Okoro, Toluwase Hezekiah Fatoki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2532-2532
Open Access | Times Cited: 26
Molecular modeling and in vitro antiproliferative activity studies of some imidazole and isoxazole derivatives
Muhammed Tılahun Muhammed, Mustafa Er, Senem Akkoç
Journal of Molecular Structure (2023) Vol. 1282, pp. 135066-135066
Closed Access | Times Cited: 25
Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights
Anjali Saxena, Suman Majee, Devalina Ray, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117681-117681
Closed Access | Times Cited: 12
Sulfonamide derivatives: Synthesis and applications
Baraa G. Alani, Khulood Saadoon Salim, Alaa Saleh Mahdi, et al.
International Journal of Frontiers in Chemistry and Pharmacy Research (2024) Vol. 4, Iss. 1, pp. 001-005
Open Access | Times Cited: 7
Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors
Jung Yoon Jang, Donghwan Kim, Nam Deuk Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8457-8457
Open Access | Times Cited: 20
Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis
Mohamed A. Elanany, Essam Eldin A. Osman, Ehab M. Gedawy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications
Ali Khoshnood, Nafiseh Farhadian, Khalil Abnous, et al.
Journal of Photochemistry and Photobiology A Chemistry (2023) Vol. 444, pp. 114972-114972
Closed Access | Times Cited: 15
Catalytic insights into laccase for sustainable remediation of multifaceted pharmaceutically active micropollutants from water matrices: A state-of-art review
Imran Ahmad, Saurabh Pal, Mohammad Waseem, et al.
Journal of Water Process Engineering (2025) Vol. 70, pp. 106901-106901
Closed Access
Mammalian nucleophagy: process and function
Fujian Ji, Enyong Dai, Rui Kang, et al.
Autophagy (2025)
Closed Access
Cytotoxicity Profile of Schiff Base Organotin(IV) Complexes: Experimental and Theoretical Approach
Manpreet Kaur, Kritika Sood, Veeranna Yempally, et al.
Journal of Fluorescence (2025)
Closed Access
Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons
S.M. Ibrahim, Muhammad Umer Khan, Iqra Khurram, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 2
Open Access
Advances of podophyllotoxin and its derivatives: Patterns and mechanisms
Rong-jia Shi, Hua‐yang Fan, Xianghua Yu, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115039-115039
Closed Access | Times Cited: 22
Molecular modeling, DFT quantum chemical analysis, and molecular docking on edotecarin, an indolocarbazole anticancer agent
Sefa Çeli̇k, Sevim Akyüz, Ayşen E. Özel
Molecular Crystals and Liquid Crystals (2022) Vol. 753, Iss. 1, pp. 27-49
Closed Access | Times Cited: 22
Strategies for the prevention or reversal of PARP inhibitor resistance
Zahi Mitri, Shaun Goodyear, Gordon B. Mills
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 10, pp. 959-975
Open Access | Times Cited: 4
The DNA-topoisomerase Inhibitors in Cancer Therapy
Stefano Mastrangelo, Giorgio Attinà, Silvia Triarico, et al.
Biomedical & Pharmacology Journal (2022) Vol. 15, Iss. 2, pp. 553-562
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top